NDC 30698-460

Lopressor HCT

Metoprolol Tartrate And Hydrochlorothiazide

Lopressor HCT is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Validus Pharmaceuticals Llc. The primary component is Metoprolol Tartrate; Hydrochlorothiazide.

Product ID30698-460_d8964894-3cd8-41c1-a844-148d2ef38a88
NDC30698-460
Product TypeHuman Prescription Drug
Proprietary NameLopressor HCT
Generic NameMetoprolol Tartrate And Hydrochlorothiazide
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date1984-12-31
Marketing CategoryNDA / NDA
Application NumberNDA018303
Labeler NameValidus Pharmaceuticals LLC
Substance NameMETOPROLOL TARTRATE; HYDROCHLOROTHIAZIDE
Active Ingredient Strength50 mg/1; mg/1
Pharm ClassesAdrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 30698-460-01

100 TABLET in 1 BOTTLE (30698-460-01)
Marketing Start Date1984-12-31
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 30698-460-01 [30698046001]

Lopressor HCT TABLET
Marketing CategoryNDA
Application NumberNDA018303
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1984-12-31
Inactivation Date2019-11-27

Drug Details

Active Ingredients

IngredientStrength
METOPROLOL TARTRATE50 mg/1

OpenFDA Data

SPL SET ID:d8964894-3cd8-41c1-a844-148d2ef38a88
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 866482
  • 866502
    • UPC Code
  • 0330698460016

    • Pharmacological Class

    • Adrenergic beta-Antagonists [MoA]
    • beta-Adrenergic Blocker [EPC]
    • Increased Diuresis [PE]
    • Thiazide Diuretic [EPC]
    • Thiazides [CS]

    NDC Crossover Matching brand name "Lopressor HCT" or generic name "Metoprolol Tartrate And Hydrochlorothiazide"

    NDCBrand NameGeneric Name
    30698-460Lopressor HCTmetoprolol tartrate and hydrochlorothiazide
    0378-0424Metoprolol Tartrate and Hydrochlorothiazidemetoprolol tartrate and hydrochlorothiazide
    0378-0434Metoprolol Tartrate and Hydrochlorothiazidemetoprolol tartrate and hydrochlorothiazide
    0378-0445Metoprolol Tartrate and Hydrochlorothiazidemetoprolol tartrate and hydrochlorothiazide
    13811-669Metoprolol Tartrate and HydrochlorothiazideMetoprolol Tartrate and Hydrochlorothiazide
    13811-670Metoprolol Tartrate and HydrochlorothiazideMetoprolol Tartrate and Hydrochlorothiazide
    13811-671Metoprolol Tartrate and HydrochlorothiazideMetoprolol Tartrate and Hydrochlorothiazide
    46708-115Metoprolol Tartrate and HydrochlorothiazideMetoprolol Tartrate and Hydrochlorothiazide
    46708-116Metoprolol Tartrate and HydrochlorothiazideMetoprolol Tartrate and Hydrochlorothiazide
    46708-117Metoprolol Tartrate and HydrochlorothiazideMetoprolol Tartrate and Hydrochlorothiazide
    62332-115Metoprolol Tartrate and HydrochlorothiazideMetoprolol Tartrate and Hydrochlorothiazide
    62332-116Metoprolol Tartrate and HydrochlorothiazideMetoprolol Tartrate and Hydrochlorothiazide
    62332-117Metoprolol Tartrate and HydrochlorothiazideMetoprolol Tartrate and Hydrochlorothiazide
    62756-368Metoprolol Tartrate and HydrochlorothiazideMetoprolol Tartrate and Hydrochlorothiazide
    62756-369Metoprolol Tartrate and HydrochlorothiazideMetoprolol Tartrate and Hydrochlorothiazide
    62756-370Metoprolol Tartrate and HydrochlorothiazideMetoprolol Tartrate and Hydrochlorothiazide
    63629-7331Metoprolol Tartrate and HydrochlorothiazideMetoprolol Tartrate and Hydrochlorothiazide
    63629-7332Metoprolol Tartrate and HydrochlorothiazideMetoprolol Tartrate and Hydrochlorothiazide

    Trademark Results [Lopressor HCT]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    LOPRESSOR HCT
    LOPRESSOR HCT
    73199102 1147454 Live/Registered
    Ciba-Geigy Corporation
    1979-01-05
    © 2025 FDA.report
    This site is not affiliated with or endorsed by the FDA.